SEARCH

SEARCH BY CITATION

References

  • Ambriz-Tututi, M., Velázquez-Zamora, D.A., Urquiza-Marín, H. and Granados-Soto, V. (2005) Analysis of the mechanism underlying the peripheral anti-nociceptive action of sildenafil in the formalin test. Eur. J. Pharmacol. 512, 121-127.
  • Colahan, P.T., Jackson, C.A., Rice, B. and Szabo, N.J. (2006) Plasma and urine concentrations of sildenafil and desmethylsildenafil and plasma cGMP following oral sildenafil administration. In: Proceedings of the 16th International Racing Analysts and Veterinarians, Eds: E.Houghton, I.Kijima-Suda, R.Wade and J.F.Wade, R&W Communications, Newmarket. pp 539-545.
  • Couetil, L.L. and Hinchcliff, K.W. (2004) Non-infectious diseases of the lower respiratory tract. In: Equine Sports Medicine and Surgery, Eds: K.W.Hinchcliff, A.J.Kaneps and R.J.Geor, Saunders Elseveir, London. pp 613-656.
  • Evans, L. (1994) The cardiovascular system: Anatomy physiology and adaptations to exercise and training. In: The Athletic Horse, Eds: D.R.Hodgson and R.J.Rose, W.B. Saunders, Philadelphia. pp 129-144.
  • Ghofrani, H.A., Reichenberger, F., Kohstall, M.G., Mrosek, E.H., Seeger, T., Olschewski, H., Seeger, W. and Grimminger, F. (2004) Sildenafil increased exercise capacity during hypoxia at low altitudes and at Mount Everest base camp. Ann. intern. Med. 141, 169-177.
  • Ghofrani, H.A., Wiedemann, R., Rose, F., Schermuly, R.T., Olschewski, H., Weissmann, N., Gunther, A., Walmrath, D., Seeger, W. and Grimminger, F. (2002a) Sildenafil for treatment of lung fibrosis and pulmonary hypertension: A randomized controlled trial. Lancet 360, 895-900.
  • Ghofrani, H.A., Wiedemann, R., Rose, F., Olschewski, H., Schermuly, R.T., Weissmann, N., Seeger, W. and Grimminger, F. (2002b) Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension. Ann. intern. Med. 136, 515-522.
  • Ghofrani, H.A., Schermuly, R.T., Rose, F., Wiedemann, R., Kohstall, M.G., Kreckel, A., Olschewski, H., Weissmann, N., Enke, B., Ghofrani, S., Seeger, W. and Grimminger, F. (2003) Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am. J. Respir. crit. care Med. 167, 1139-1141.
  • Hinchcliff, K.W., Morley, P.S. and Guthrie, A.J. (2009) Efficacy of furosemide for prevention of exercise-induced pulmonary hemorrhage in Thoroughbred racehorses. J. Am. vet. med. Ass. 235, 76-86.
  • Jackson, G., Benjamin, N., Jackson, N. and Allen, M. (1999) Effects of sildenafil citrate on human hemodynamics. Am. J. Cardiol. 83, 13C-20C.
  • Jain, N.K., Patil, C.S., Singh, A. and Kulkarni, S.K. (2001) Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Brain Res. 909, 170-178.
  • Kindig, C.A., McDonough, P., Finton, G., Poole, D.C. and Erickson, H.H. (2001a) Efficacy of nasal strip and furosemide in mitigating EIPH in Thoroughbred horses. J. appl. Physiol. 91, 1396-1400.
  • Kindig, C.A., McDonough, P., Finley, M.R., Behnke, B.J., Richardson, T.E., Marlin, D.J., Erickson, H.H. and Poole, D.C. (2001b) NO inhalation reduces pulmonary arterial pressure but not haemorrhage in maximally exercising horses. J. appl. Physiol. 91, 2674-2678.
  • Lester, G., Clark, C., Rice, B., Steible-Hartless, C. and Vetro-Widenhouse, T. (1999) Effect of timing and route of administration of furosemide on pulmonary haemorrhage and pulmonary arterial pressure in exercising Thoroughbred racehorses. Am. J. vet. Res. 60, 22-28.
  • McKane, S.A. and Slocombe, R.F. (1999) Sequential changes in bronchoalveolar cytology after autologous blood inoculation. Equine vet. J., Suppl. 30, 126-130.
  • Mahmud, A., Hennessy, M. and Feely, J. (2001) Effect of sildenafil on blood pressure and arterial wave reflection in treated hypertensive men. J. hum. Hypertens. 15, 707-713.
  • Manohar, M. and Goetz, T.E. (1996) Pulmonary vascular pressures of exercising Thoroughbred horses with and without endoscopic evidence of EIPH. J. appl. Physiol. 81, 1589-1593.
  • Manohar, M., Goetz, T.E., Rothenbaum, P. and Humphrey, S. (2000) Clenbuterol administration does not attenuate the exercise-induced pulmonary arterial, capillary or venous hypertension in strenuously exercising Thoroughbred horses. Equine vet. J. 32, 546-550.
  • Mixcotal-Zecuatl, T., Aguirre-Bañuelos, P. and Granados-Soto, V. (2000) Sildenafil produces antinociception and increases morphine antinociception in the formalin test. Eur. J. Pharmacol. 400, 81-87.
  • Newton, J.R., Rogers, K., Marlin, D.J., Wood, J.L.N. and Williams, R.B. (2005) Risk factors for epistaxis on British racecourses: evidence for locomotory impact-induced trauma contribution to the aetiology of exercise-induced pulmonary haemorrhage. Equine vet. J. 37, 402-411.
  • Nichols, D.J., Muirhead, G.J. and Harness, J.A. (2002) Pharmacokinetics of sildenafil citrate after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality. Br. J. Clin Pharm. 53, 5S-12S.
  • Ricart, A., Marstany, J., Fort, N., Leal, C., Pages, T. and Viscor, G. (2005) Effects of sildenafil on the human response to acute hypoxia and exercise. High Altitude Med. Biol. 6, 43-49.
  • Richalet, J.P., Gratadour, P., Robach, P., Pham, I., Dechaux, M., Joncquiert-Latarjet, A., Mollard, P., Brugniaux, J. and Cornolo, J. (2005) Sildenafil inhibits altitude-induced hypoxemia and pulmonary hypertension. Am. J. Respir. crit. care Med. 171, 275-281.
  • Rudy, J. and Kahler, M. (2002) Liquid-chromatography mass spectrometric method for screening and confirmation of sildenafil and metabolites in equine urine and plasma. Available at: http://www.testingintegrityprogram.org (accessed 11 August 2010).
  • Sastry, B.K., Narasimhan, C., Reddy, N.K., Anand, B., Prakash, G.S., Raju, P.R. and Kumar, D.N. (2002) A study of clinical efficacy of sildenafil in patients with primary pulmonary hypertension. Indian Heart J. 54, 410-414.
  • Schermuly, R.T., Kreisselmeier, K.P., Ghofrani, H.A., Yilmaz, H., Butrous, G., Ermert, L., Ermert, M., Weissmann, N., Rose, F., Guenther, A., Walmrath, D., Seeger, W. and Grimminger, F. (2004) Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats. Am. J. Respir. crit. care Med. 169, 39-45.
  • Schroter, R.C., Marlin, D.J. and Denny, E. (1998) Exercise-induced pulmonary haemorrhage (EIPH) in horses results from locomotory impact induced trauma - a novel, unifying concept. Equine vet. J. 30, 186-192.
  • Takahashi, T., Hiraga, A., Ohmura, H., Kai, M. and Jones, J.H. (2001) Frequency of and risk factors for epistaxis associated with exercise-induced pulmonary haemorrhage in horses: 251,609 race starts (1992–1997). J. Am. vet. med. Ass. 218, 1462-1464.
  • Vardi, Y., Klein, L., Nassar, S., Sprecher, E. and Gruenwald, I. (2002) Effects of sildenafil citrate (Viagra) on blood pressure in normotensive and hypertensive men. Urol. 59, 747-752.
  • Webb, D., Freestone, S., Allen, M., and Muirhead, G. (1999) Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist. Am J. Cardiol 83, 21C-28C.
  • Weimann, J., Ullrich, R., Hromi, J., Fujino, Y., Clark, M.W., Bloch, K.D. and Zapol, W.M. (2000) Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension. Anesthesiol. 92, 1702-1712.
  • Wilkens, H., Guth, A., Konig, J., Forestier, N., Cremers, B., Hennen, B., Bohm, M. and Sybrecht, G.W. (2001) Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension. Circulation 104, 1218-1222.
  • Zhao, L., Mason, N.A., Morrell, N.W., Kojonazarov, B., Sadykov, A., Maripov, A., Mirrakhimov, M.M., Aldashev, A. and Wilkins, M. (2001) Sildenafil inhibits hypoxia-induced pulmonary hypertension. Circulation 104, 424-428.
  • Zusman, R.M., Morales, A., Glasser, D.B. and Osterloh, I.H. (1999) Overall cardiovascular profile of sildenafil citrate. Am. J. Cardiol. 83, 35C-44C.